Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Songke
Contact Songke, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Upregulation of TCF1 and BCL11B in CD8+ effector T cells predicts favorable response to ibrutinib in patients with chronic lymphocytic leukemia
Abstract The Bruton’s kinase inhibitor ibrutinib has become a cornerstone in the treatment of chronic lymphocytic leukemia (CLL). Previous studies reported an association between upregulation of TCF1 and BCL11B transcription factors with favorable survival outcomes in CLL patients. This study aimed to investigate the correlation of TCF1 and BCL11B with response to ibrutinib.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Songke
Contact Songke, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack